Status: Recruiting
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
The purpose of this study is to evaluate prospectively the safety and performance of the MOBYBOX System in the veno-arterial configuration in patients with cardiorespiratory failure or in the veno-venous configuration in patients with severe respiratory failure.
Participants needed: 60
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Hemovent GmbHUpdated: May 31, 2025Locations: 4Duration: 30 Days
Eligibility criteria
A Murray score ≥ 3.0 and/or severe hypoxemia with A PaO2/FIO2 > 100 mm on 0.9 FI... [+5]
High pressure ventilation (FIO2 > 0.9 and Pplateau > 30 cm H2O) or high FIO2 req... [+14]